0001493152-26-012701
SEC filingTevogen Bio Holdings Inc. received written notice from The Nasdaq Stock Market LLC on March 20, 2026, confirming it regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. The matter is now closed following a 1-for-50 reverse stock split effective March 6, 2026.